HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomized prospective study of cefoxitin versus piperacillin in appendicectomy.

Abstract
A randomized prospective study of antibiotic prophylaxis using a single dose of either cefoxitin or piperacillin is presented. The trial was carried out in Al Ain Hospital in the period 1989-1992 on 250 adult patients with non-perforated appendicitis. One group (124 patients) received 2 g cefoxitin, the other group (126 patients) 2 g piperacillin. Antibiotics were administered intravenously in the operating theatre immediately before surgery. Wound infection occurred in three patients, 2.4% of the cefoxitin group and in five patients (4%) of the second group (with no significant difference). The commonest infecting organisms were Escherichia coli (5 out of 8). Mean hospital stay for patients with wound infection was 15 days (range 12-21) compared with 6 days, (range 4-8) for non-infected cases. Prophylactic cefoxitin or piperacillin were each therefore similarly effective in minimizing the rate of wound infections in patients with non-perforated appendicitis.
AuthorsI M Salam, K H Abu Galala, Y I el Ashaal, V P Chandran, N N Asham, A J Sim
JournalThe Journal of hospital infection (J Hosp Infect) Vol. 26 Issue 2 Pg. 133-6 (Feb 1994) ISSN: 0195-6701 [Print] England
PMID7911147 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cefoxitin
  • Piperacillin
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Appendectomy
  • Appendicitis (surgery)
  • Cefoxitin (therapeutic use)
  • Combined Modality Therapy
  • Female
  • Humans
  • Infusions, Intravenous
  • Length of Stay (statistics & numerical data)
  • Male
  • Middle Aged
  • Piperacillin (therapeutic use)
  • Premedication (methods)
  • Prospective Studies
  • Surgical Wound Infection (epidemiology, microbiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: